亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Multiple Myeloma Cell Lines with Either Glucocorticoid Sensitivity and Resistance

技術優勢
Allcell lines are derived from same patient
詳細技術說明
Tissue culture cell lines derived from the peripheral blood of a multiple myeloma patient. #researchtool #cellline
*Abstract

Northwestern researchers have created tissue culture celllines derived from the peripheral blood of a multiple myeloma patient who hadbeen treated with glucocorticoids and become resistant to that treatment.  The blood was separated on a Ficoll gradientto isolate the compartment containing the myeloma cells. These isolated cellswere expanded in tissue culture and named MM.1 cells. The MM.1 parental cellline was further sub-cloned by limiting dilution to isolate cells that aresensitive to the killing effects of glucocorticoids. The resultant cells arenamed MM.1S.  The MM.1 parental cell linewas also treated with glucocorticoids at increasing doses over time and theresultant cells were not killed by high doses of glucocorticoids. These cellsare named MM.1R.  These cell lines havebeen widely used for the pre-clinical development of therapeutics designed totreat multiple myeloma. There are many other human myeloma cell lines inexistence, but these cell lines are unique in that bothglucocorticoid-sensitive and- resistant sub-clones were derived from the samepatient. This is a very attractive model for the study of how glucocorticoidresistance develops in patients.

*Inventors
Nancy KrettSteven Rosen*
*Publications
Goldman-LeikinRE, Salwen HR, Herst CV, et al. (1980) Characterization of a novel myeloma cellline. Journal of Laboratory ClinicalInvestigation.  113:  335-45.Moalli PA,Pillay S, Weiner D, Leikin R and Rosen ST (1992)  A mechanism of resistance to glucocorticoidsin multiple myeloma: transient expression of a truncated glucocorticoidreceptor mRNA.  Blood.  79:  213-22.
國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備